Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer

被引：0
|
作者：
Craig A. Vargo
Michael J. Berger
Gary Phillips
Ewa Mrozek
机构：
[1] The Ohio State University Wexner Medical Center,Department of Pharmacy, The James Cancer Hospital and Solove Research Institute
[2] The Ohio State University,Center for Biostatistics
[3] The Ohio State University Wexner Medical Center,Division of Medical Oncology, Department of Internal Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Everolimus; Adverse events; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2913 / 2918
页数：5
相关论文
共 50 条
  • [31] Everolimus in first-line treatment of advanced premenopausal breast cancer: Results from MIRACLE (everoliMus trIal foR AdvanCed premenopausaL brEast cancer) study
    Fan, Ying
    Sun, Tao
    Shao, Zhimin
    Zhang, Qingyuan
    Ouyang, Quchang
    Tong, Zhongsheng
    Wang, Shusen
    Luo, Yang
    Teng, Yuee
    Wang, Xiaojia
    Wang, Shu
    Liu, Qiang
    Feng, Jifeng
    Shen, Kunwei
    Song, Yanqiu
    Wang, Jiayu
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Xu, Binghe
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Everolimus-related adverse events in neuroendocrine tumors and comparative considerations with breast and renal cancer: a critical overview
    Martins, Diana
    Lambrescu, Ioana
    Barucca, Viola
    Fazio, Nicola
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 525 - 536
  • [33] Does the occurrence of adverse life events in patients with breast cancer lead to a change in illness behaviour?
    Siegfried Geyer
    Dorothee Noeres
    Mariya Mollova
    Heike Sassmann
    Alexandra Prochnow
    Mechthild Neises
    Supportive Care in Cancer, 2008, 16
  • [34] Does the occurrence of adverse life events in patients with breast cancer lead to a change in illness behaviour?
    Geyer, Siegfried
    Noeres, Dorothee
    Mollova, Mariya
    Sassmann, Heike
    Prochnow, Alexandra
    Neises, Mechthild
    SUPPORTIVE CARE IN CANCER, 2008, 16 (12) : 1407 - 1414
  • [35] STOMATITIS PREVENTION DURING EVEROLIMUS/EXEMESTANE TREATMENT FOR METASTATIC BREAST CANCER: A PHASE 2 STUDY OF STEROID-BASED MOUTHWASH
    Ajmera, Archana
    Weikel, Dianna
    Lindsay, Sheila
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E96 - E97
  • [36] Everolimus in combination with carboplatin: a promising treatment with low toxicity in heavily pretreated metastatic breast cancer
    Schwarzlose-Schwarck, S.
    Regierer, A. C.
    Martus, P.
    Schulz, C. -O.
    Liu, H.
    Schefe, J. H.
    Possinger, K.
    Scholz, C. W.
    Eucker, J.
    ONKOLOGIE, 2011, 34 : 118 - 118
  • [37] Pneumocystis Pneumonia and Acute Kidney Injury Induced by Everolimus Treatment in a Patient with Metastatic Breast Cancer
    Nakamura, Mayuko
    Matsunuma, Ryoichi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Tsuneizumi, Michiko
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 170 - 175
  • [38] EFFICACY AND SAFETY OF EVEROLIMUS IN THE TREATMENT OF METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hyderboini, R. K.
    Thode, R.
    Malode, M.
    Pinigani, V
    Nathani, J.
    Veeranki, P.
    Paladugu, G.
    Nadimpally, J.
    Kumar, N.
    Palakurthy, P.
    Vsn, M.
    Dang, A.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [39] Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer
    Dempsey, Jacqueline M.
    Xi, Jingyue
    Henry, N. Lynn
    Rae, James M.
    Hertz, Daniel L.
    PHYSIOLOGICAL GENOMICS, 2018, 50 (02) : 98 - 99
  • [40] The Importance of Keeping Patients With Metastatic Colorectal Cancer on Treatment Through the Management of Adverse Events
    Grothey, Axel
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (10) : 15 - 19
12345